SEIU Reports Workers at 11 Tenet Healthcare Hospitals Across California Overwhelmingly Vote to Strike, Calling for Contract to Address Pandemic Safety

October 27, 2020

SEIU reports Workers at 11 Tenet Healthcare hospitals in California have voted overwhelmingly to go on strike to demand that the giant hospital chain bargain in good faith with employees over health, safety, and other working conditions in their facilities, as caregivers continue to risk their lives caring for patients with COVID-19.

SEIU notes the strike vote covers 4,300 workers at the 11 facilities who are members of SEIU-United Healthcare Workers West. The vote margin was 96 percent in favor of the strike.

Tenet has rejected most of the workers’ proposals on pandemic safety. Workers are asking Tenet to go beyond the minimal federal guidelines to make sure the most comprehensive protections are in place.

“We are scared to come to work knowing we are at great risk of exposure to COVID-19,” said Gisella Thomas, a respiratory therapist at Desert Regional Medical Center in Palm Springs. “We want to work with management at our hospitals to increase protections for our health, our patients’ health, our families’ health, and the health of our communities. We have put forth a pandemic safety proposal that addresses issues workers are concerned about, like staffing, PPE, and increased COVID-19 testing for employees.”

Tenet has made more than $1 billion in profits in the first three quarters of 2020 and received more than $250 million in taxpayer bailout money in California alone. Tenet’s Chief Executive Officer Ron Rittenmeyer was paid more than $24 million in 2019, and the chain’s president and chief operating officer Saum Sutaria was paid nearly $14 million.

“We are calling on Tenet to increase its investment in worker safety and staffing in the middle of the worst pandemic in over a century – to ensure the safety of healthcare workers, our patients, and our entire communities.”

The strike will occur at the following Tenet hospitals in California:

INDIO: John F. Kennedy Memorial Hospital
JOSHUA TREE: High Desert Medical Center
LAKEWOOD: Lakewood Regional Medical Center
LOS ALAMITOS: Los Alamitos Medical Center
MANTECA: Doctors Hospital of Manteca
MODESTO: Doctors Medical Center
PALM SPRINGS: Desert Regional Medical Center
SAN LUIS OBISPO: Sierra Vista Regional Medical Center
SAN RAMON: San Ramon Regional Medical Center
TEMPLETON: Twin Cities Community Hospital
TURLOCK: Emanuel Medical Center

 

SourceSEIU

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”